» Articles » PMID: 29496669

Next-generation Sequencing of Idiopathic Multicentric and Unicentric Castleman Disease and Follicular Dendritic Cell Sarcomas

Overview
Journal Blood Adv
Specialty Hematology
Date 2018 Mar 3
PMID 29496669
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Castleman disease (CD) is a rare lymphoproliferative disorder subclassified as unicentric CD (UCD) or multicentric CD (MCD) based on clinical features and the distribution of enlarged lymph nodes with characteristic histopathology. MCD can be further subtyped based on human herpes virus 8 (HHV8) infection into HHV8-associated MCD, HHV8/idiopathic MCD (iMCD), and polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin change (POEMS)-associated MCD. In a subset of cases of UCD, an associated follicular dendritic cell sarcoma (FDCS) may be seen. Although numerous reports of the clinical and histologic features of UCD, MCD, and FDCS exist, an understanding of the genetic and epigenetic landscape of these rare diseases is lacking. Given this paucity of knowledge, we analyzed 15 cases of UCD and 3 cases of iMCD by targeted next-generation sequencing (NGS; 405 genes) and 3 cases of FDCS associated with UCD hyaline vascular variant (UCD-HVV) by whole-exome sequencing. Common amplifications of , , and were seen in 1 iMCD and 1 UCD case; the iMCD case also had a somatic L295Q mutation. This iMCD patient also showed clinicopathologic features consistent with a specific subtype known as Castleman-Kojima disease (thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly [TAFRO] clinical subtype). Additionally, 1 case of UCD-HVV showed amplification of the cluster of histone genes on chromosome 6p. FDCS associated with UCD-HVV showed mutations and copy number changes in known oncogenes, tumor suppressors, and chromatin structural-remodeling proteins.

Citing Articles

Spatial and Single Cell Mapping of Castleman Disease Reveals Key Stromal Cell Types and Cytokine Pathways.

Smith D, Eichinger A, Rech A, Wang J, Esteva E, Seyedian A bioRxiv. 2024; .

PMID: 39314418 PMC: 11419132. DOI: 10.1101/2024.09.09.609717.


scRNA-seq reveals the landscape of immune repertoire of PBMNCs in iMCD.

Yin X, Liu Y, Lv Z, Ding S, Ma L, Yang M Oncogene. 2024; 43(37):2795-2805.

PMID: 39147879 DOI: 10.1038/s41388-024-03128-8.


Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report.

Xiao P, Wang Q, Dong Z, Su J, Chen Y, Fan W Open Life Sci. 2024; 19(1):20220898.

PMID: 38947769 PMC: 11211873. DOI: 10.1515/biol-2022-0898.


TAFRO Syndrome and COVID-19.

Tane M, Kosako H, Sonoki T, Hosoi H Biomedicines. 2024; 12(6).

PMID: 38927495 PMC: 11200813. DOI: 10.3390/biomedicines12061287.


Extranodal follicular dendritic cell sarcoma of the lung.

Jha T, Sharma A, Kalakkunath S, Mullick S, Rahul E, Dixit M Indian J Thorac Cardiovasc Surg. 2024; 40(2):219-223.

PMID: 38389765 PMC: 10879473. DOI: 10.1007/s12055-023-01599-0.


References
1.
Fajgenbaum D, van Rhee F, Nabel C . HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014; 123(19):2924-33. DOI: 10.1182/blood-2013-12-545087. View

2.
Challen G, Sun D, Jeong M, Luo M, Jelinek J, Berg J . Dnmt3a is essential for hematopoietic stem cell differentiation. Nat Genet. 2011; 44(1):23-31. PMC: 3637952. DOI: 10.1038/ng.1009. View

3.
Quek L, Ferguson P, Metzner M, Ahmed I, Kennedy A, Garnett C . Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia. Blood Adv. 2018; 1(3):193-204. PMC: 5737177. DOI: 10.1182/bloodadvances.2016000760. View

4.
Yang L, Rau R, Goodell M . DNMT3A in haematological malignancies. Nat Rev Cancer. 2015; 15(3):152-65. PMC: 5814392. DOI: 10.1038/nrc3895. View

5.
Hartmann L, Dutta S, Opatz S, Vosberg S, Reiter K, Leubolt G . ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation. Nat Commun. 2016; 7:11733. PMC: 4895769. DOI: 10.1038/ncomms11733. View